| Record ID | marc_records_scriblio_net/part19.dat:106972889:1117 |
| Source | Scriblio |
| Download Link | /show-records/marc_records_scriblio_net/part19.dat:106972889:1117?format=raw |
LEADER: 01117cam 2200325 a 4500
001 87043139 //r92
003 DLC
005 19920428133545.3
008 871103s1988 nyua b 000 0 eng c
010 $a 87043139 //r92
020 $a0881673285 (pbk.)
040 $aDNLM/DLC$cDLC$dDLC
050 00 $aRC684.P74$bP74 1988
060 $aWG 300 P927
082 00 $a616.1/23061$219
245 00 $aPrenylamine :$ba novel approach to myocardial protection /$ceditors, Allan S. Manning, George L. Szendey.
260 0 $aNew York, N.Y. :$bRaven Health Care Communications,$cc1988.
300 $axii, 128 p. :$bill. ;$c24 cm.
504 $aIncludes bibliographies.
650 0 $aPrenylamine$xTesting.
650 0 $aVasodilators.
650 0 $aMyocardial depressants.
650 0 $aMyocardial infarction$xChemotherapy.
650 0 $aArrhythmia$xChemotherapy.
650 0 $aAngina pectoris$xChemotherapy.
650 2 $aCoronary Disease$xprevention & control.
650 2 $aPrenylamine$xpharmacodynamics.
700 10 $aManning, Allan S.
700 10 $aSzendey, George L.
740 01 $aNovel approach to myocardial protection.